Kyle Mcmurphy is a pharmacist who is specialized in Ambulatory Care in Dallas, Texas. Patients can reach him at 5151 Maple Ave, Dallas or contact him on 214-590-6323. Active license number of Kyle Mcmurphy is 41964 for Ambulatory Care in Texas. Kyle Mcmurphy is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Kyle Mcmurphy speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Kyle Mcmurphy
Specialization:
Ambulatory Care
Gender:
Male
Location:
5151 Maple Ave, Dallas, Texas, 75235-8136
Phone:
214-590-6323
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Kyle Mcmurphy are as mentioned below.
NPI Number:
1235559519
NPI Enumeration Date:
24 Apr, 2014
NPI Last Update On:
29 Sep, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kyle Mcmurphy are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
41964
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
5200 Harry Hines Blvd, Dallas, Texas
Zip:
75235-7709
Phone Number:
214-590-6323
Fax Number:
--
Patients can reach Kyle Mcmurphy at 5151 Maple Ave, Dallas, Texas or can call on phone at 214-590-6323.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.